Skip to main content
Log in

Akutes Leberversagen

Wie viel Diagnostik und Therapie braucht mein Patient?

Acute liver failure

How much diagnostic work-up and therapy does my patient need?

  • Schwerpunkt
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Das akute Leberversagen ist eine Multisystemerkrankung, die durch eine schwere Leberinsuffizienz mit hepatischer Enzephalopathie gekennzeichnet ist, durch apoptotischen oder nekrotischen Untergang von Leberparenchym verursacht wird und ohne vorbekannte Lebererkrankung auftritt. Die klinische Herausforderung liegt in der frühen Identifizierung von Patienten mit schlechter Prognose und deren rechtzeitiger Listung zur Transplantation. Der vorliegende Beitrag beleuchtet die Grundlagen der Entscheidungsfindung zur Transplantation, aktuelle Aspekte der Intensivtherapie sowie die sklerosierende Cholangitis des Intensivpatienten als Ursache des subakuten Leberversagens.

Abstract

Acute liver failure is a multisystem disease with predominantly sudden and severe hepatic injury and hepatic encephalopathy caused by apoptotic or necrotic hepatocyte damage. The clinical challenge in patients with acute liver failure is to promptly identify those with poor prognosis and refer them for emergency liver transplantation. This review article highlights the main aspects of decision making in the setting of acute liver failure, summarizes new aspects of its critical care management and gives an overview of sclerosing cholangitis in the critically ill patient, an under-recognized disease entity that can progress to acute liver failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Acharya SK, Bhatia V, Sreenivas V et al (2009) Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 136:2159–2168

    Article  PubMed  CAS  Google Scholar 

  2. Ananthakrishnan AN, McGinley EL, Saeian K (2008) Effect of hospital volume and teaching status on outcomes of acute liver failure. Liver Transpl 14:1347–1356

    Article  PubMed  Google Scholar 

  3. Andrade RJ, Lucena MI, Fernandez MC et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521

    PubMed  Google Scholar 

  4. Antonides C, Berry P, Wendon J et al (2008) The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 49:845–861

    Article  Google Scholar 

  5. Bechmann LP, Jochum C, Kocabayoglu P et al (2010) Cytokeratin-18 based modification of the MELD score improves prediction of spontaneous survival after acute liver failure. J Hepatol 53:639–647

    Article  PubMed  CAS  Google Scholar 

  6. Bernal W, Hall C, Karvellas CJ et al (2007) Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46:1844–1852

    Article  PubMed  CAS  Google Scholar 

  7. Bernal W, Cross TJS, Auzinger G et al (2009) Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol 50:306–313

    Article  PubMed  Google Scholar 

  8. Bernal W, Auzinger G, Dhawan A et al (2010) Acute liver failure. Lancet 376:190–201

    Article  PubMed  Google Scholar 

  9. Bernuau J, Nicand E, Durand F (2008) Hepatitis E-associated acute liver failure in pregnancy: an Indian puzzle. Hepatology 48:1380–1382

    Article  PubMed  Google Scholar 

  10. Bismuth H, Samuel D, Castaing D et al (1995) Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 222:109–119

    Article  PubMed  CAS  Google Scholar 

  11. Bower WA, Johns M, Margolis HS et al (2007) Population-based surveillance for acute liver failure. Am J Gastroenterol 102:2459–2463

    Article  PubMed  Google Scholar 

  12. Brandsaeter B, Hockerstedt K, Friman S et al (2002) Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation – 12 years experience in the nordic countries. Liver Transpl 8:1055–1062

    Article  PubMed  Google Scholar 

  13. Canbay A (2010) Leberparameter und Einschätzung der Leberleistung. In: Canbay A, Gerken G (Hrsg) Die Leber in der Intensivmedizin. Aesopus, Linkenheim-Hochstetten, S 24–37

  14. Canbay A, Jochum C, Bechmann LP et al (2009) Acute liver failure in a metropolitan area in Germany: a retrospective study (2002–2008). Z Gastroenterol 47:807–813

    Article  PubMed  CAS  Google Scholar 

  15. Christensen E (2010) Glucocorticosteroids in acute alcoholic hepatitis: the evidence of a beneficial effect is getting even weaker. J Hepatol 53:390–391

    Article  PubMed  Google Scholar 

  16. Cornberg M, Protzer U, Dollinger MM et al (2007) Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virus-Infektion – Upgrade der Leitlinie. Z Gastroenterol 45:1–50

    Google Scholar 

  17. Craig DG, Ford AC, Hayes PC et al (2010) Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 31:1064–1076

    Article  PubMed  CAS  Google Scholar 

  18. Dalton HR, Bendall R, Ijaz S et al (2008) Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 8:698–709

    Article  PubMed  Google Scholar 

  19. Dechêne A, Sowa JP, Gieseler RK et al (2010) Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 52:1008–1016

    Article  PubMed  Google Scholar 

  20. Depka M von (2002) Hämostaseologische Methoden. In: Depka M von (Hrsg) Blutgerinnung – Aktuelle Aspekte der Physiologie, Pathophysiologie, Klinik, Diagnostik, Prophylaxe und Therapie. Uni-Med, Bremen, S 116–128

  21. Dureja P, Lucey MR (2010) The place of liver transplantation in the treatment of severe alcoholic hepatitis. J Hepatol 52:759–764

    Article  PubMed  Google Scholar 

  22. Engler S, Elsing C, Flechtenmacher C et al (2003) Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 52:688–693

    Article  PubMed  CAS  Google Scholar 

  23. Escorsell A, Mas A, de la Mata M, and the Spanish Group for the Study of Acute Liver Failure (2007) Acute liver failure in Spain: analysis of 267 cases. Liver Transpl 13:1389–1395

    Article  PubMed  Google Scholar 

  24. Escudie L, Franqoz C, Vinel JP et al (2007) Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol 46:466–473

    Article  PubMed  Google Scholar 

  25. Fearing MK, Israel EJ, Sahai I et al (2011) A 9-month-old boy with acute liver failure. N Engl J Med 364:1545–1556

    Article  PubMed  CAS  Google Scholar 

  26. Garg H, Sarin SK, Kumar M et al (2011) Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 53:774–780

    Article  PubMed  CAS  Google Scholar 

  27. Gelbmann CM, Ruemmele P, Wimmer M et al (2007) Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 102:1221–1229

    Article  PubMed  Google Scholar 

  28. Graham BB, Kaul DR, Saint S et al (2009) Kiss of death. N Engl J Med 360:2564–2568

    Article  PubMed  CAS  Google Scholar 

  29. Hadem J, Schneider AS, Manns MP (2008) Pathophysiologie und Therapie des akuten Leberversagens. Intensivmedizin Up2Date 1:17–33

    Article  Google Scholar 

  30. Hadem J, Stiefel P, Bahr MJ et al (2008) Prognostic implications of lactate, bilirubin and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol 6:339–345

    Article  PubMed  CAS  Google Scholar 

  31. Hadem J, Tacke F, Bruns T et al (2011) Acute liver failure in Germany 2008–2009: a retrospective analysis by the acute liver failure study group Germany (abstract). J Hepatol 54:S367

    Article  Google Scholar 

  32. Harrison PM, Wendon JA, Gimson AE et al (1991) Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324:1852–1857

    Article  PubMed  CAS  Google Scholar 

  33. Harry R, Ausinger G, Wendon J (2002) Clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 36:395–402

    Article  PubMed  CAS  Google Scholar 

  34. Hui C-K, Cheung WWW, Zhang H-Y et al (2006) Kinetics and risk of de novo hepatitis B infection in HbsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 131:59–68

    Article  PubMed  CAS  Google Scholar 

  35. Jaeger C, Mayer G, Henrich R et al (2006) Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment and follow-up. Endoscopy 38:730–734

    Article  PubMed  CAS  Google Scholar 

  36. Jalan R, Olde Damink SW, Hayes PC et al (2004) Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 41:613–620

    Article  PubMed  CAS  Google Scholar 

  37. Jalan R, Williams R, Bernuau J (2006) Paracetamol: are therapeutic doses entirely safe? Lancet 368:2195–2196

    Article  PubMed  Google Scholar 

  38. Jochum C, Gieseler RK, Gawlista I et al (2009) Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion 80:235–240

    Article  PubMed  CAS  Google Scholar 

  39. Katoonizadeh A, Decaestecker J, Wilmer A et al (2007) MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int 27:329–334

    Article  PubMed  Google Scholar 

  40. Kneiseler G, Bachmann HS, Bechmann LP et al (2010) A rare case of propofol-induced acute liver failure and literature review. Case Rep Gastroenterol 4:57–65

    Article  PubMed  Google Scholar 

  41. Kulaksiz H, Heuberger D, Engler S et al (2008) Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 40:214–218

    Article  PubMed  CAS  Google Scholar 

  42. Lange CM, Bojunga J, Hofmann WP et al (2009) Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function. Hepatology 50:2001–2006

    Article  PubMed  CAS  Google Scholar 

  43. Larsen FS, Murphy N, Bernal W et al (2011) The prophylactic effect of mild hypothermia to prevent brain edema in patients with acute liver failure: results of a multicenter, randomized, controlled trial (abstract). J Hepatol 54:S26

    Article  Google Scholar 

  44. Lee WM, Hynan LS, Rossaro L et al (2009) Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 137:856–864

    Article  PubMed  CAS  Google Scholar 

  45. Leithead JA, Ferguson JW, Bates CM et al (2009) The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 58:443–449

    Article  PubMed  CAS  Google Scholar 

  46. Lisman T, Caldwell SH, Burroughs AK et al (2010) Hemostasis and thrombosis in patients with liver diasease: the ups and downs. J Hepatol 53:362–371

    Article  PubMed  Google Scholar 

  47. Mathurin P (2010) The use of corticosteroids in severe alcohol hepatitis: we need to look beyond this controversy. J Hepatol 53:392–393

    Article  PubMed  Google Scholar 

  48. Mindikoglu AL, Magder LS, Regev A (2009) Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the united network for organ sharing database. Liver Transpl 15:719–729

    Article  PubMed  Google Scholar 

  49. Müller-Beißenhirtz H (2010) Gerinnungsstörungen bei Lebererkrankungen. In: Canbay A, Gerken G (Hrsg) Die Leber in der Intensivmedizin. Aesopus, Linkenheim-Hochstetten, S 38–65

  50. Murphy N, Auzinger G, Bernal W et al (2004) The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hematology 39:464–470

    CAS  Google Scholar 

  51. Norvell JP, Blei AT, Jovanovic BD et al (2007) Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl 13:1428–1434

    Article  PubMed  Google Scholar 

  52. O’Grady JG, Alexander GJ, Hayllar KM et al (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439–445

    Google Scholar 

  53. O’Grady JG, Schalm SW, Williams R (1993) Acute liver failure: redefining the syndromes. Lancet 342:273–275

    Article  Google Scholar 

  54. Ostapowicz G, Fontana RJ, Schiødt FV et al (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947–954

    PubMed  Google Scholar 

  55. Polson J, Lee WM (2005) AASLD position paper: the management of acute liver failure. Hematology 41:1179–1197

    Google Scholar 

  56. Rank N, Michel C, Haertel C et al (2000) N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med 28:3799–3807

    Article  PubMed  CAS  Google Scholar 

  57. Renner EL (2007) How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King‘s College criteria, or something else? J Hepatol 46:554–557

    Article  PubMed  Google Scholar 

  58. Reuben A, Koch DG, Lee WM (2010) Acute Liver Failure Study Group: drug-induced acute liver failure: results of a US multicenter, prospective study. Hepatology 52:2065–2076

    Article  PubMed  Google Scholar 

  59. Rezende G, Roque-Afonso AM, Samuel D et al (2003) Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hematology 38:613–638

    Google Scholar 

  60. Rolando N, Gimson A, Wade J et al (1993) Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 17:196–201

    Article  PubMed  CAS  Google Scholar 

  61. Ruemmele P, Hofstaedter F, Gelbmann CM (2009) Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 6:287–295

    Article  PubMed  Google Scholar 

  62. Saliba F, Camus C, Durand F et al (2008) Randomized controlled multicenter trial evaluating the efficacy and safety of albumin dialysis with MARS in patients with fulminant and subfulminant hepatic failure (abstract). Hepatology 48:4

    Article  Google Scholar 

  63. Schmidt L, Larsen F (2007) MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 45:789–796

    Article  PubMed  CAS  Google Scholar 

  64. Smilkstein MJ, Knap GL, Kulig KW et al (1998) Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 319:1557–1562

    Article  Google Scholar 

  65. Squires RH Jr, Shneider BL, Bucuvalas J et al (2006) Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 148:652–658

    Article  PubMed  Google Scholar 

  66. Taylor RM, Davern T, Munoz S et al (2006) Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology 44:1589–1597

    Article  PubMed  CAS  Google Scholar 

  67. Tillmann HL, Hadem J, Leifeld L et al (2006) Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 13:256–263

    Article  PubMed  CAS  Google Scholar 

  68. Trey C, Davidson CS (1970) The management of fulminant hepatic failure. Prog Liver Dis 3:282–298

    PubMed  CAS  Google Scholar 

  69. Vaquero J, Polson J, Chung C et al (2003) Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125:755–764

    Article  PubMed  Google Scholar 

  70. Walsh TS, Hopton P, Philips BJ et al (1998) The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. Hepatology 27:1332–1340

    Article  PubMed  CAS  Google Scholar 

  71. Walsh TS, Wigmore SJ, Hopton P et al (2000) Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med 28:649–654

    Article  PubMed  CAS  Google Scholar 

  72. Wendon J, Manns MP, Alexander G et al (2010) Acute liver failure: current European perspective (abstract). J Hepatol 52:S13

    Article  Google Scholar 

  73. Westbrook RH, Yeoman AD, Joshi D et al (2010) Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant 10:2520–2526

    Article  PubMed  CAS  Google Scholar 

  74. Whitfield K, Rambaldi A, Wetterslev J et al (2009) Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev 4:CD007339

    PubMed  Google Scholar 

  75. Yantorno SE, Kremers WK, Ruf AE et al (2007) MELD is superior to King’s college criteria and Clichy’s criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 13:822–828

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Hadem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hadem, J., Schneider, A. & Manns, M. Akutes Leberversagen. Internist 52, 804–814 (2011). https://doi.org/10.1007/s00108-010-2793-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-010-2793-0

Schlüsselwörter

Keywords

Navigation